TargeGen Company
TargeGen, Inc., a vascular biology-focused biopharmaceutical company, discovers and develops small molecule kinase inhibitors that target.
Investors
Technology:
Data-driven Technologies
Industry:
PharmTech
Headquarters:
San Diego, California, United States
Founded Date:
2002
Employees Number:
11-50
Funding Status:
M&A
Investors Number:
10
Total Funding:
$92.9M
Last Funding Type:
Series D
Register and Claim Ownership